MRI in corticobasal degeneration

M Grisoli1, V Fetoni, M Savoiardo

  • 1Departments of Neuroradiology, Istituto Nazionale Neurologico "C. Besta", Milano, ItalyDepartments of Neurology, Istituto Nazionale Neurologico "C. Besta", Milano, Italy.

Insights

Magnetic resonance imaging (MRI) can detect asymmetric parietal atrophy, aiding the diagnosis of corticobasal degeneration. This neuroimaging technique supports clinical findings and helps differentiate it from other neurological disorders.

Area of Science:

  • Neurology
  • Neuroimaging
  • Radiology

Background:

  • Corticobasal degeneration (CBD) is a progressive neurological disorder.
  • It presents with asymmetric motor symptoms and cognitive decline.
  • Definitive diagnosis requires post-mortem examination.

Purpose of the Study:

  • To evaluate the utility of MRI in detecting asymmetric brain atrophy in suspected CBD cases.
  • To assess MRI's role in supporting clinical diagnosis and differential diagnosis.

Main Methods:

  • Brain MRI was performed on ten patients with clinical suspicion of CBD.
  • MRI scans were reviewed by a radiologist unaware of the clinical presentation side.
  • Original MRI reports were also analyzed.

Main Results:

  • MRI revealed asymmetric cortical atrophy, predominantly in the posterior frontal and parietal regions, contralateral to clinical symptoms.
  • Asymmetry was often missed on initial readings.
  • Review of MRI findings confirmed the ability to detect asymmetrical parietal atrophy.

Conclusions:

  • MRI can detect asymmetrical parietal atrophy, supporting the clinical diagnosis of corticobasal degeneration.
  • Radiologists must be vigilant for subtle asymmetries to aid in diagnosis.
  • MRI findings help differentiate CBD from other neurodegenerative conditions.